1. Targeting the PD-1/PD-L1 Immune Checkpoint in EGFR-Mutated or ALK-Translocated Non-Small-Cell Lung Cancer

   • Olivier Bylicki
   • Nicolas Paleiron
   • Christos Chouaid

   Leading Article 18 June 2017 Pages: 563 - 569

   

2. Insulin-Like Growth Factor (IGF) Pathway Targeting in Cancer: Role of the IGF Axis and Opportunities for Future Combination Studies

   • Aaron Simpson
   • Wilfride Petnga
   • Thomas Bogenrieder

   Review Article Open access 16 August 2017 Pages: 571 - 597

   

3. Bevacizumab in Colorectal Cancer: Current Role in Treatment and the Potential of Biosimilars

   • Lee S. Rosen
   • Ira A. Jacobs
   • Ronald L. Burkes

   Review Article Open access 11 August 2017 Pages: 599 - 610

   

4. Predictive Markers of Response to Everolimus and Sunitinib in Neuroendocrine Tumors

   • Diana Martins
   • Francesca Spada
   • IEO ENETS Center of Excellence for GEP NETs

   Review Article 21 June 2017 Pages: 611 - 622

   

5. Targeting the Wnt Pathway in Cancer: A Review of Novel Therapeutics

   • Roya Tabatabai
   • Yuliya Linhares
   • Alain Mita

   Review Article 26 June 2017 Pages: 623 - 641

   

6. Dose and Schedule Selection of the Oral Proteasome Inhibitor Ixazomib in Relapsed/Refractory Multiple Myeloma: Clinical and Model-Based Analyses

   • Neeraj Gupta
   • Huyuan Yang
   • Karthik Venkatakrishnan

   Original Research Article Open access 12 August 2017 Pages: 643 - 654

   

7. A Phase II Multicentre, Open-Label, Proof-of-Concept Study of Tasquinimod in Hepatocellular, Ovarian, Renal Cell, and Gastric Cancers

   • Bernard Escudier
   • Sandrine Faivre
   • Amit Oza

   Original Research Article 10 August 2017 Pages: 655 - 661

   

8. EGFR Mutation Testing of non-squamous NSCLC: Impact and Uptake during Implementation of Testing Guidelines in a Population-Based Registry Cohort from Northern New Zealand

   • Mark McKeage
   • Mark Elwood
   • Donald Love

   Original Research Article 11 July 2017 Pages: 663 - 675

   

9. The pan-Bcl2 Inhibitor AT101 Activates the Intrinsic Apoptotic Pathway and Causes DNA Damage in Acute Myeloid Leukemia Stem-Like Cells

   • Leisi Zhang
   • Yong Zhou
   • Bing Xu

   Original Research Article 14 July 2017 Pages: 677 - 687

   

10. Lung Adenocarcinoma Survival in EGFR-Mutated African-Caribbean Patients: A Multicenter Study in the French West Indies

    • Nicolas Leduc
    • Vincent Atallah
    • Vincent Molinie

    Short Communication 18 June 2017 Pages: 689 - 693

    

11. A Combination of Testosterone and White Blood Cell Count as a Predictive Factor of Overall Survival in Localized Prostate Cancer

    • Daniel Taussky
    • Denis Souliéres
    • Guila Delouya

    Short Communication 15 July 2017 Pages: 695 - 701

    

12. Erratum to: Is 1,25-Dihydroxyvitamin D3 Receptor Expression a Potential Achilles’ Heel of CD44+ Oral Squamous Cell Carcinoma Cells?

    • Martin Grimm
    • Beshr Shokri
    • Siegmar Reinert

    Erratum 26 July 2017 Pages: 703 - 703